The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
 
Razelle Kurzrock
Leadership - CureMatch
Stock and Other Ownership Interests - CureMatch
Consulting or Advisory Role - Actuate Therapeutics; Loxo; Sequenom
Speakers' Bureau - Roche
Research Funding - Foundation Medicine (Inst); Genentech (Inst); Guardant Health (Inst); Incyte (Inst); Merck Serono (Inst); Pfizer (Inst); Sequenom (Inst)
 
Rahul Parulkar
No Relationships to Disclose
 
Timothy Joseph Yeatman
No Relationships to Disclose
 
Wafik S. El-Deiry
Stock and Other Ownership Interests - Oncoceutics; p53-Therapeutics
Research Funding - Bayer; Loxo; Morphotek; Tarmeta Biosciences
Patents, Royalties, Other Intellectual Property - Patent on TIC10 (ONC201); Patents pending on the use of small molecules to target mutant p53
Other Relationship - Caris Life Sciences
 
Timothy J. Pluard
Consulting or Advisory Role - Pfizer
Speakers' Bureau - Genentech/Roche; Novartis; Pfizer
 
Chad Garner
Employment - Becton Dickinson (I); Human Longevity, Inc; NantWorks
Stock and Other Ownership Interests - Becton Dickinson (I); Human Longevity, Inc
 
Sandeep K. Reddy
Employment - Caris Life Sciences; NantHealth
Leadership - Caris Life Sciences; NantHealth
Stock and Other Ownership Interests - Caris Life Sciences; NantHealth
Speakers' Bureau - Merck
Patents, Royalties, Other Intellectual Property - Patent WO/2016/141169; Patent WO/2016/141169